Eosinophilic Esophagitis: Budesonide Dosing Study

We are comparing the effectiveness and tolerability of taking budesonide once daily versus twice daily for adults with esophagus inflammation. This study aims to see if both dosing schedules work equally well and how they affect patients' quality of life.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Jorveza
Jorveza is a medicine used to treat eosinophilic esophagitis, an allergic inflammation of the esophagus that can cause swallowing problems.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Budesonide
Budesonide is a steroid substance that reduces inflammation in the airways to help control asthma and other respiratory conditions.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Bul03

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Acorspray
Aeromax
Airbudenid

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medical University Of Graz
Klinische Abteilung für Gastroenterologie und Hepatologie
Graz, Austria
Ordensklinikum Linz GmbH
Internal medicine IV
Linz, Austria
Noe LGA Gesundheit Region Mitte GmbH
Innere 2, Gastroenterologie
Sankt Pölten, Austria

Sponsor: Dr. Falk Pharma GmbH
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.